DSPE-PEG1000-K237 is a PEG compound composed of DSPE and the KDR-targeting peptide (K237). K237 functionally disrupts the interaction between VEGF and KDR receptors, producing significant biological effects such as inhibiting angiogenesis and tumor growth. DSPE-PEG1000-K237 is applicable for drug delivery.
Target-Kategorie:
Liposome
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
